Indonesia Next Generation Sequencing (NGS) Market to 2032
Overview
The Indonesia Next Generation Sequencing (NGS) Market is expected to reach a 231.02 USD Billion by 2032 and is projected to grow at a CAGR of 17.13% from 2025 to 2032.
Revenue, 2024 (USD Billion)
91.65
Forecast, 2032 (USD Billion)
231.02
CAGR, 2024 - 2032
17.13%
Report Coverage
Indonesia
Indonesia Next Generation Sequencing (NGS) Market 2018-2032 USD Billion
Indonesia Next Generation Sequencing (NGS) Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 91.65 USD Billion
- Projected Market Size (2032): 231.02 USD Billion
- CAGR (2025-2032): 17.13%
Key Findings of Indonesia Next Generation Sequencing (NGS) Market
- The Indonesia Next Generation Sequencing (NGS) Market was valued at 231.02 USD Billion in 2024.
- The Indonesia Next Generation Sequencing (NGS) Market is likely to grow at a CAGR of 17.13% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Drug & Biomarker Discovery in Application Segment accounted for the largest share of the market with a revenue of 91.65 USD Billion
- The fastest growing segment Pharmaceuticals Microbiology in Application Segment grew Fastest with a CAGR of 18.11% during the forecast period from 2024 to 2032.
Indonesia Next Generation Sequencing (NGS) Market Scope
Indonesia Next Generation Sequencing (NGS) Market Segmentation & Scope
Product & Service
- Instruments
- Services
- Consumables
Technology
- Others
- Sequencing By Ligation (SBL)
- Sequencing By Synthesis (SBS)
Application
- Others
- Food Pathogen Screening
- Agricultural & Animal Research
- Diagnostics
- Pharmaceuticals Microbiology
- Drug & Biomarker Discovery
- Precision Medicine
Distribution Channel
- Others
- Retail Sales
- Direct Tender
End User
- Others
- Contract Research Organizations (CROS)
- Clinical Laboratories
- Hospitals & Clinics
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
Indonesia Next Generation Sequencing (NGS) Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 91.65 USD Billion |
| Market Value in 2032 | 231.02 USD Billion |
| CAGR (2025-2032) | 17.13% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Product & Service,Technology,Application,Distribution Channel,End User |
Regional Insights:
-
Leading Market (2024-2032): Indonesia, leading in terms of revenue 91.65 USD Billion in 2024
- Key Country: Indonesia, leading in terms of revenue with value of 91.65 USD Billion in 2024.
Segments and Scope
-
Indonesia Next Generation Sequencing (NGS) Market to 2032, By Product & Service
- Consumables is the largest segment in Indonesia Next Generation Sequencing (NGS) Market to 2032 with a revenue of 48.94 USD Billion in the year 2024.
- Services is the Fastest growing segment in Indonesia Next Generation Sequencing (NGS) Market to 2032 with a Growth rate of 17.15 % in forecast period 2025-2032.
-
Indonesia Next Generation Sequencing (NGS) Market to 2032, By Technology
- Sequencing By Synthesis (SBS) is the largest segment in Indonesia Next Generation Sequencing (NGS) Market to 2032 with a revenue of 57.98 USD Billion in the year 2024.
- Sequencing By Synthesis (SBS) is the Fastest growing segment in Indonesia Next Generation Sequencing (NGS) Market to 2032 with a Growth rate of 17.29 % in forecast period 2025-2032.
-
Indonesia Next Generation Sequencing (NGS) Market to 2032, By Application
- Drug & Biomarker Discovery is the largest segment in Indonesia Next Generation Sequencing (NGS) Market to 2032 with a revenue of 91.65 USD Billion in the year 2024.
- Pharmaceuticals Microbiology is the Fastest growing segment in Indonesia Next Generation Sequencing (NGS) Market to 2032 with a Growth rate of 17.13 % in forecast period 2025-2032.
-
Indonesia Next Generation Sequencing (NGS) Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in Indonesia Next Generation Sequencing (NGS) Market to 2032 with a revenue of 57.66 USD Billion in the year 2024.
- Direct Tender is the Fastest growing segment in Indonesia Next Generation Sequencing (NGS) Market to 2032 with a Growth rate of 17.33 % in forecast period 2025-2032.
-
Indonesia Next Generation Sequencing (NGS) Market to 2032, By End User
- Pharmaceutical & Biotechnology Companies is the largest segment in Indonesia Next Generation Sequencing (NGS) Market to 2032 with a revenue of 39.42 USD Billion in the year 2024.
- Pharmaceutical & Biotechnology Companies is the Fastest growing segment in Indonesia Next Generation Sequencing (NGS) Market to 2032 with a Growth rate of 17.87 % in forecast period 2025-2032.
Indonesia Next Generation Sequencing (NGS) Market Company Share Analysis
| Company Name |
|
||
| Merck KGaA | |||
| Thermo Fisher Scientific Inc. | |||
| QIAGEN | |||
| Charles River Laboratories | |||
Indonesia Next Generation Sequencing (NGS) Market Geographical Sales Distribution, 2018-2032 USD Billion
Indonesia Next Generation Sequencing (NGS) Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Indonesia Next Generation Sequencing (NGS) Market is segmented based on Segmentation Product & Service,Technology,Application,Distribution Channel,End User.
Indonesia Next Generation Sequencing (NGS) Market was valued at USD 91.65(Revenue in USD Billion) in 2020.
Indonesia Next Generation Sequencing (NGS) Market is projected to grow at a CAGR of 17.13% during the forecast period of 2024 to 2032.
The Drug & Biomarker Discovery segment is expected to dominate the Indonesia Next Generation Sequencing (NGS) Market, holding a largest market share of 91.65 USD Billion in 2024
Coming Soon....
Indonesia Next Generation Sequencing (NGS) Market Scope
Indonesia Next Generation Sequencing (NGS) Market Segmentation & Scope
Product & Service
- Instruments
- Services
- Consumables
Technology
- Others
- Sequencing By Ligation (SBL)
- Sequencing By Synthesis (SBS)
Application
- Others
- Food Pathogen Screening
- Agricultural & Animal Research
- Diagnostics
- Pharmaceuticals Microbiology
- Drug & Biomarker Discovery
- Precision Medicine
Distribution Channel
- Others
- Retail Sales
- Direct Tender
End User
- Others
- Contract Research Organizations (CROS)
- Clinical Laboratories
- Hospitals & Clinics
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
Frequently Asked Questions
The Indonesia Next Generation Sequencing (NGS) Market is segmented based on Segmentation Product & Service,Technology,Application,Distribution Channel,End User.
Indonesia Next Generation Sequencing (NGS) Market was valued at USD 91.65(Revenue in USD Billion) in 2020.
Indonesia Next Generation Sequencing (NGS) Market is projected to grow at a CAGR of 17.13% during the forecast period of 2024 to 2032.
The estimated market value of the Indonesia Next Generation Sequencing (NGS) Market for final year is USD 231.02 (USD Billion).
Indonesia Next Generation Sequencing (NGS) Market Company Profiling
Frequently Asked Questions
The Indonesia Next Generation Sequencing (NGS) Market is segmented based on Segmentation Product & Service,Technology,Application,Distribution Channel,End User.
Indonesia Next Generation Sequencing (NGS) Market was valued at USD 91.65(Revenue in USD Billion) in 2020.
Indonesia Next Generation Sequencing (NGS) Market is projected to grow at a CAGR of 17.13% during the forecast period of 2024 to 2032.
The estimated market value of the Indonesia Next Generation Sequencing (NGS) Market for final year is USD 231.02 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.